Technion and top US university researchers have conducted lab trials of an implantable ‘living pancreas’. It senses glucose, produces insulin, while its crystalline shield prevents immune system rejection. It paves the way for self-regulating, long-term diabetes treatment without daily injections.

https://www.ynetnews.com/health_science/article/hyfay5gdwe